Posts Tagged 'zostavax'

Merck Moves to Consolidate as Zostavax Lawsuits Multiply

zostavax cases consolidated to MDLNow facing close to 60 lawsuits over its shingles vaccine Zostavax, Merck has petitioned for an MDL, or multidistrict litigation, to be created to help resolve the cases. 57 Zostavax lawsuits currently span nine federal courts, and the corporation only expects that number to grow. The lawsuits stem from allegations that Zostavax – marketed under the promise of preventing shingles – can actually cause the condition instead.

Zostavax is recommended ...

continue reading...

Zostavax Label Updated to Reflect Shingles Virus Risk

Zostavax label receives subtle yet important updateThe contraindication section of the label for shingles vaccine Zostavax recently received a subtle, yet important, update.

The previous label made no direct mention of the fact that, if taken by someone who has a suppressed or inactive immune system, Zostavax could actually cause shingles in the vaccinated patient. This is an important point, as the patient would be administered the vaccine specifically to avoid the painful – and potentially life-threatening ...

continue reading...

Zostavax Competitor Wins Unanimous Recommendation for Approval

shingrix wins approval recommendationAfter considering the data, every member of an FDA advisory panel convened this month voted to recommend the approval of Shingrix – a new shingles vaccine developed and marketed by GlaxoSmithKline.

Data was not based solely on efficacy, or effectiveness. Rather, the data also took the vaccine’s safety into consideration. Panel members were “very impressed” with that data on both fronts and – according to Reuters – believe that Shingrix is ...

continue reading...

New Lawsuit Claims Zostavax Shingles Link

Zostavax linked to causing shinglesA lawsuit filed in mid-July seeks compensation and damages for 18 patients who claim that Merck’s anti-shingles vaccine Zostavax actually gave them the condition they were seeking to avoid. Hailing from a variety of states, the plaintiffs have come together to sue Merck in its home state of New Jersey.

Zostavax is targeted at people aged 50 years or older and the CDC has gone so far as to issue ...

continue reading...

Flux Continues as Merck Announces Cuts

merck announces job cutsUp to 360 employees of Merck’s 7,400 New Jersey employees could either lose their jobs or see their positions relocated as the company shifts efforts toward exploratory biology.

The cuts will come from the company’s pre-clinical, discovery, and early development group. Citing a need to break into emerging research arenas, the change in strategy will result in staffing level changes in Kenilworth and Rahway, New Jersey as well as North Wales, Pennsylvania.

Positions ...

continue reading...